Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira Pastan

Showing results (11-20 of 340) with videos related to

Pageof 34
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
In vitro antibody affinity maturation targeting germline hotspotsMitchell Ho, Ira Pastan
Biomolecules|July 8, 2020
Mechanisms of Resistance to Immunotoxins Containing <i>Pseudomonas</i> Exotoxin A in Cancer TherapyMichael Dieffenbach, Ira Pastan
The FEBS Journal|May 19, 2011
A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancerJohn E Weldon, Ira Pastan
Best Practice & Research. Clinical Haematology|April 3, 2003
Immunobiological treatments of hairy-cell leukaemiaRobert J Kreitman, Ira Pastan
Best Practice & Research. Clinical Haematology|November 29, 2015
Immunoconjugates in the management of hairy cell leukemiaRobert J Kreitman, Ira Pastan
Plos Pathogens|June 16, 2010
Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirsEdward A Berger, Ira Pastan
Current Drug Targets|November 1, 2006
Immunotoxins in the treatment of hematologic malignanciesRobert J Kreitman, Ira Pastan
The Oncologist|October 20, 2019
Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell LeukemiaRobert J Kreitman, Ira Pastan
Current Opinion in Investigational Drugs (London, England : 2000)|August 21, 2002
Immunotoxins in cancer therapyIra Pastan, Robert J Kreitman
Best Practice & Research. Clinical Haematology|September 26, 2006
BL22 and lymphoid malignanciesRobert J Kreitman, Ira Pastan
Pageof 34

Showing results (11-20 of 340) with videos related to

Sort By:
Pageof 34
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
In vitro antibody affinity maturation targeting germline hotspotsMitchell Ho, Ira Pastan
Biomolecules|July 8, 2020
Mechanisms of Resistance to Immunotoxins Containing <i>Pseudomonas</i> Exotoxin A in Cancer TherapyMichael Dieffenbach, Ira Pastan
The FEBS Journal|May 19, 2011
A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancerJohn E Weldon, Ira Pastan
Best Practice & Research. Clinical Haematology|April 3, 2003
Immunobiological treatments of hairy-cell leukaemiaRobert J Kreitman, Ira Pastan
Best Practice & Research. Clinical Haematology|November 29, 2015
Immunoconjugates in the management of hairy cell leukemiaRobert J Kreitman, Ira Pastan
Plos Pathogens|June 16, 2010
Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirsEdward A Berger, Ira Pastan
Current Drug Targets|November 1, 2006
Immunotoxins in the treatment of hematologic malignanciesRobert J Kreitman, Ira Pastan
The Oncologist|October 20, 2019
Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell LeukemiaRobert J Kreitman, Ira Pastan
Current Opinion in Investigational Drugs (London, England : 2000)|August 21, 2002
Immunotoxins in cancer therapyIra Pastan, Robert J Kreitman
Best Practice & Research. Clinical Haematology|September 26, 2006
BL22 and lymphoid malignanciesRobert J Kreitman, Ira Pastan
Pageof 34